Background: Prenatal alcohol exposure (PAE) causes neurodevelopmental disability. Clinical and animal studies show gestational iron deficiency (ID) exacerbates PAE's behavioral and growth deficits. In rat, PAE manifests an inability to establish iron homeostasis, increasing hepcidin (maternal and fetal), and fetal liver iron while decreasing brain iron and promoting anemia. Here, we hypothesize dietary iron fortification during pregnancy may mitigate alcohol's disruption of fetal iron homeostasis.
P RENATAL ALCOHOL EXPOSURE (PAE) is a leading cause of neurodevelopmental disability in the United
States (NIAAA, 2015) . Even with increased public understanding of the negative effects of PAE, 1 in 10 pregnant women in the United States use alcohol and 1 in 33 report binge drinking in the previous month (CDC, 2015) . In the United States, 24 to 48 per 1,000 children are estimated to exhibit fetal alcohol spectrum disorder (FASD; May et al., 2018) . PAE can cause lifelong physical, cognitive, and behavioral abnormalities (NIAAA, 2015) . It is estimated that the United States alone spends $4 billion annually on FASDrelated disabilities (Lupton et al., 2004) . Because of its severity and prevalence in both developed and developing countries, identification and implementation of nutritional interventions to mitigate the negative consequences of PAE are a priority.
Iron deficiency (ID) is the most common micronutrient deficiency in the world and affects approximately 30% of the global population and 50% of women of reproductive age (Asobayire et al., 2001; Beard, 2003) . Iron is essential for cellular energy generation and red cell formation, and in neurodevelopment, is required for neurotransmitter formation as well as neuronal myelination (Beard, 2003; Lozoff et al., 2006) . Clinically, maternal ID strongly correlates with worsened outcomes in FASD including body growth, birthweight and size, and head circumference (Carter et al., 2007 (Carter et al., , 2012 . Our previous work in a rat model of PAE affirmed that the combination of maternal prenatal ID and PAE worked synergistically to impair associative learning and white matter formation (Huebner et al., 2015; Rufer et al., 2012) . Molecular studies in those animals suggest the interaction between PAE and ID is caused, in part, because alcohol disrupts maternal and fetal iron homeostasis, producing fetal anemia and brain iron inadequacy, while the liver accumulates iron stores due to alcohol's induction of hepcidin, which serves to limit iron absorption and transport (Huebner et al., 2016) .
Because PAE dysregulates fetal iron utilization, and because ID exacerbates alcohol's damage, dietary iron supplementation under PAE conditions may improve fetal outcomes. Iron metabolism is tightly regulated, as free iron is highly toxic and causes oxidative damage (Tussing-Humphreys et al., 2012) . Therefore, optimization of dietary iron intake according to individual and population needs is paramount. Multiple factors must be considered when determining the amount of iron supplementation to provide, such as an individual's diet and the duration of public health intervention (Beard, 2000) . A recent study indicated that oral iron and folate supplementation were able to significantly improve maternal iron biomarkers in ID Tanzanian women as well as decrease perinatal mortality (Abioye et al., 2016) . However, whether pregnant women should receive iron supplementation in the absence of ID anemia remains under debate (Siu and USPSTF, 2015) .
The primary goal of this study was to test the hypothesis that maternal consumption of an iron-fortified (IF) diet prior to and during pregnancy would restore iron homeostasis in both the dam and the fetus in the presence of PAE. Multiple studies have shown that regulation of hepcidin, the primary stimulus for iron trafficking, is disrupted in the presence of alcohol exposure, and alcohol significantly decreases hepcidin levels in nonpregnant individuals, although much of that work is in the context of alcoholic liver disease (Harrison-Findik, 2009; Ohtake et al., 2007) . In contrast, iron fortification alone could increase hepcidin levels (Pantopoulos et al., 2012) . Therefore, our secondary goal was to examine whether iron fortification had detrimental effects upon iron homeostasis, divalent metal content, and oxidative stress.
MATERIALS AND METHODS

Animals and Diets
We used our established model of dietary iron intervention (Huebner et al., 2015 (Huebner et al., , 2016 Rufer et al., 2012) . Nulliparous, 8-week-old Long-Evans female rats (Envigo, Richmond, IN) were randomly assigned to consume ad libitum either an iron-sufficient (IS; 100 ppm Fe; TD.06016; Teklad, Madison, WI) or IF (500 ppm; TD.110880) diet at least 2 weeks prior to and throughout pregnancy. The diet composition is based on AIN-93G (Table S1) , and food intake did not differ by treatment. Gestational day (GD) 0.5 was defined as the morning a vaginal plug was discovered. Litters containing <9 or >15 pups were excluded from all analyses to minimize differences in iron distribution across litters within a treatment group. Fetuses were analyzed on GD20.5, which is the day prior to birth and is when placental iron transport is largely complete; it is the equivalent of human fetus at 39 to 40 weeks with respect to maternal-fetal iron transfer (Rao and Georgieff, 2002) . On GD20.5, following isoflurane overdose and maternal perfusion, maternal and fetal blood and tissues were collected, flash frozen in liquid nitrogen, and stored at À80°C until further analysis. A subset of liver specimens was formalin-fixed and paraffin-blocked for histological analysis. All protocols were approved by the Institutional Animal Care and Use Committee.
Alcohol Exposure
We used our established model of alcohol exposure (Huebner et al., 2016) . On GD0.5 IS and IF dams were randomly assigned to receive either 5.0 g/kg body weight alcohol (PAE; 200 proof ethanol, USP grade; Decon Labs, King of Prussia, PA) given as 40% alcohol in water, or isocaloric maltodextrin (M) in water. Both alcohol and M were administered by gastric gavage and were given daily as 2 half-dose 2 hours apart on GD13.5 through GD19.5.
Tissue Iron Analysis
Iron, copper, and zinc content were quantified at GD20.5 in maternal liver, fetal brain, and fetal liver using inductively coupled plasma atomic emission spectroscopy (UW Soil Science Analysis Laboratory, Madison, WI) as described (Huebner et al., 2016) . Fetal tissue could not be perfused; therefore, nonheme iron content was quantified using the method of Rebouche and colleagues (2004) and expressed as lg/g wet weight and total lg of iron. Total red blood cell (RBC) iron was calculated from hemoglobin values in Table 3 and using the formula: mg Fe in circulation = blood volume (90 ml/kg rat weight) 9 hemoglobin (g/ml) 9 3.47 mg Fe/g hemoglobin (Fomon et al., 1988) . To assess how iron status and alcohol treatment affected iron distribution across fetal compartments, we calculated the ratios of liver nonheme iron (from Fig. 4A ) to total RBC iron (Table 3 ), brain nonheme iron (Fig. 4B) , and relative hepcidin expression (Fig. 1B) ; values for ID fetuses were from Huebner and colleagues (2016) .
Hematologic Measures
On GD20.5, dam and fetal blood samples were collected by cardiac puncture and placed immediately into a lithium heparin microtainer. Hematologic measures were determined using a pocH-100i TM hematology analyzer (Sysmex, Mundelein, IL) . In addition to erythrocyte counts (RBC), hemoglobin, hematocrit, and the RBC indices mean cell volume (MCV), mean cell hemoglobin (MCH), and mean cell hemoglobin concentration (MCHC) were obtained. Unbound and total iron binding capacity was determined by TIBC kit (Pointe Scientific, Canton, MI). Plasma ferritin (FTN) was quantified by ELISA (Immunology Consultants, Newberg, OR). Wright-Giemsa smears were used to assess cellular morphology and count nucleated RBCs. A total of 100 nucleated cells were counted to distinguish between nucleated RBC and white blood cell (WBC) counts because the hematology analyzer is unable to do so. The WBC count is corrected by subtracting nucleated RBC.
To quantify RBC pockets within fetal liver, formalin-fixed, paraffin-embedded fetal liver specimens were sectioned at 10 lm and stained with either H&E or with enhanced Prussian blue, which is a sensitive indicator of Fe2+ and Fe3+ deposits (Schroeter et al., 2004) . Two central veins were centered and photographed at 209 using SPOT Advanced software (Diagnostic Instruments, Sterling, MI). Using NIH ImageJ (Bethesda, MD), thresholding for dark purple of nuclei of early RBC or the rust of ePBR staining was defined by changing the image type to an RGB Stack. Percent threshold staining area compared with the whole area of the slide was quantified by defining minimum and maximum threshold for each stack.
Western Blot Analysis
This was performed as previously described (Huebner et al., 2016) . Briefly, 10 lg protein per sample was analyzed. Primary antibodies for iron homeostatic proteins were used in a 1:2,000 dilution against FTN heavy chain (sc-25617; Santa Cruz Biotechnology, Dallas TX), Tf (sc-30159; Santa Cruz Biotechnology), transferrin receptor-1 (TfRc; 13-6890; Life Technologies, Rockville, MD), and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (1:5,000, G8795; Sigma-Aldrich, St. Louis, MO). Immunoreactive (IR) bands were visualized utilizing isotype-specific IR-dye conjugated secondary antibodies (A-21109, Life Technologies; #926-68022, 1:15,000, LI-COR, Lincoln, NB; #610-132-007, 1:30,000, Rockland Immunochemicals, Gilbertville, PA). Band IR intensities were quantified using the Odyssey infrared imaging system and Image Studio software (both from LI-COR). Molecular weights for bands of interest were calculated against color-tagged protein standards (Precision Plus Protein; Bio-Rad, Hercules, CA). Protein band intensity was normalized to GAPDH expression within the same sample, and protein abundance was compared between samples; PAE does not affect GAPDH abundance in this model, as determined by comparison with total protein loaded per lane (Huebner et al., 2016) . Samples were assayed in triplicate.
Real-Time Quantitative Polymerase Chain Reaction
Methodology conforms to minimal information for publication of quantitative real-time experiments (MIQE) guidelines for quantitative polymerase chain reaction (PCR) analysis. RNA extraction, cDNA synthesis, and quantitative PCR protocol were performed as described (Flentke et al., 2004) . Hepcidin (Hamp, NM_053469.1) primer sequences were as follow: forward, 5
0 . GAPDH (NM_017008.4) primer sequences were as follows: forward, 5 0 -TGACAAAGTGGACATTGTTGC-3 0 , reverse 5 0 -CTTGCCGTGGGTAGAGTCAT-3 0 . Samples were run in triplicate, and hepcidin expression was normalized to GAPDH (NM_017008.4) content. The mean relative expression change was calculated using the 2 ÀDDCT method (Livak and Schmittgen, 2001 ). Neither alcohol nor iron status affected GAPDH transcript abundance in this model.
DNPH Assay for Protein Carbonylation
Total protein carbonyl content in maternal rat liver was determined using 2, 4-dinitrophenylhydrazine (DNPH) as described (Reznick and Packer, 1994) . Liver tissue was homogenized in 50 mM phosphate buffer containing 0.1% digitonin, 1 mM EDTA, and an antiprotease cocktail. Following centrifugation to remove solids, nucleic acids were removed from the supernatant using a 1% streptomycin sulfate precipitation, and protein was quantified using the BCA assay. Each protein sample at 5 mg/ml was combined with 4 volumes of 20 mM DNPH in 2.5 M HCl and incubated for 1 hour in the dark with occasional vortex mixing. A sample omitting DNPH was run in parallel. The protein was precipitated twice in a final concentration of 10% trichloroacetic acid and then washed 3 times in ethyl acetate/ethanol (1:1, v/v). The final precipitate was dissolved at 37°C in 400 ll of 6 M guanidine hydrochloride. The carbonyl content was calculated from the absorbance at 375 nm of the DNPH-treated proteins and using a molar extinction coefficient e of 22,000 M À1 cm
À1
. For each sample, a parallel sample that omitted DNPH was run as a background control. Total protein concentration was determined by absorption at 280 nm. Carbonyl content is expressed as mol carbonyl per mg total protein.
Data Analysis
Animals in the IS and IF cohorts were generated contemporaneously with the ID cohort described in Huebner and colleagues (2016) . Comparison of the IS and ID cohorts is presented in Huebner and colleagues (2016) , and comparison of IS and IF cohorts is In fetal liver at GD20.5, PAE was associated with a trend to elevated hepcidin expression in IS fetuses, whereas feeding the IF diet to dams attenuated hepcidin expression in IF-PAE fetuses to levels not different from IS-M controls. Values are means AE SEMs of hepcidin mRNA content, normalized to GAPDH mRNA content, and expressed relative to IS-M, representing 6 litters and sampling 2 fetuses/litter. Figure panels present overall p-values as determined by 2-factor ANOVA, followed by post hoc analysis in which means without a common letter are significantly different, p < 0.05. IS, iron-sufficient; IF, iron-fortified; M, maltodextrin; PAE, prenatal alcohol exposure. The IS-M and IS-PAE dams studied here were previously studied in Huebner and colleagues (2016) , but the presented values were generated from separate aliquots of frozen liver that has not been previously analyzed. The IS-M and IS-PAE fetal values presented here were all generated from fetuses that have not been previously analyzed. The IF values have not been previously reported. described herein. Select data for the IS-M and IS-PAE litters described in Huebner and colleagues (2016) Tables 2 and 3 ). All IS-M and IS-PAE data for the mRNA and protein quantitation (Figs 1 to 3), liver hematology (text), and the protein carbonylation (Fig. S1 ) are new data generated from samples not previously analyzed. All IF-M and IF-PAE data are from animals not previously analyzed or published.
In the data analysis, for all fetal measurements excluding CBCs, the litter was classified as the experimental unit with 2 fetuses sampled per litter per end point and comparing consistent uterine position, because previous work shows intralitter variation for experimental end points is lower than interlitter variation within a treatment cohort. For CBCs, fetal blood was pooled and analyzed across an entire litter. A 2-way analysis of variance (ANOVA) was employed using SAS Procedure MIXED (SAS Institute, Cary, NC) to determine differences due to dietary iron status and PAE. Fixed effects were iron status, PAE, and the interaction of iron status and PAE. The analysis included the random effect of litter. Each dependent variable was tested with 2 models utilizing equal or unequal variance among the 4 treatment groups. A likelihood ratio test was employed to determine which model was statistically appropriate. When the effect of iron status, PAE, and/or their interaction was significant (p < 0.05), the ANOVA was followed by a priori comparisons of the 4 treatments to one another in a planned, pairwise fashion (e.g., IS-M vs. IS-PAE.) utilizing Tukey's HSD test to identify treatment differences while limiting overall comparison-wide error rate. Differences were considered significant at p < 0.05. Values are presented as mean AE SEM unless otherwise noted.
RESULTS
Maternal-Fetal Weight Parameters
Neither iron status nor PAE affected litter size (Table 1) and final maternal weight did not differ between treatments.
Iron status had no significant effect upon pregnancy weight gain, but a nonsignificant trend was seen for increased gain in IF versus IS counterparts (p = 0.068). PAE dams have significantly lower gestational weight gain compared with their M-exposed controls (p = 0.035). Maternal brain, heart, and liver weights did not significantly differ by treatment (not shown).
PAE reduced total fetal weight (p < 0.001) and reduced absolute brain (p = 0.030), liver (p < 0.001), and placental (p = 0.034) weights regardless of maternal diet (Table 1) . When expressed as a percentage of body weight, PAE fetuses had higher brain and heart sizes irrespective of diet (p < 0.001), suggestive of organ sparing at the expense of body growth. The placental-to-body weight ratio was significantly higher in PAE pregnancies (p < 0.001), and iron fortification did not mitigate this. Multiple comparisons test revealed that the IS-PAE group had a significantly higher placental-to-body weight ratio compared with IS-M (p = 0.032) and IF-M (p = 0.038), whereas the IF-PAE values did not significantly differ from control values.
Maternal-Fetal Hepcidin mRNA Expression
We have previously shown that PAE alters the expression of signals crucial for the regulation of iron fate in both the maternal and the fetal compartments (Huebner et al., 2016) . One such signal is hepcidin, a key regulator of iron absorption and transport, which is increased by PAE in both IS and ID dams and fetuses. We tested if dietary iron fortification would normalize its expression. IS-PAE dams had significantly elevated liver hepcidin mRNA expression when compared to IS-M controls (p = 0.024). Iron fortification normalized maternal hepcidin expression in the presence of PAE (Fig. 1A) and did not further affect hepcidin in controls. With respect to the fetus, a trend was present showing elevated hepcidin in IS-PAE fetuses and levels increased 66%, similar to that reported previously, while levels in IF-M and IF-PAE fetuses were essentially equivalent to IS-M controls (Fig. 1B) . The lack of excessive stimulation of hepcidin expression by the IF diet suggested that the 5-fold increase in dietary iron intake was not excessive.
Maternal-Fetal FTN and Tf
The hepcidin expression results suggested that providing dams with an IF diet prior to and during pregnancy may have helped to lessen the impact of PAE on iron sensing and/ or utilization. To explore this further, we evaluated the maternal and fetal expression of FTN, Tf, and TfRc, which help regulate iron flux between liver and extrahepatic compartments. We reported previously that PAE blunted the response of these proteins to ID (Huebner et al., 2016) . In maternal liver, alcohol itself did not affect the content of these proteins in the IS animals (Fig. 2) . Iron fortification elevated hepatic FTN and reduced TfRc, a response consistent with the dams' elevated iron intake (Pantopoulos et al., 2012) . Under the IF-PAE combination, these effects of IF were attenuated, and FTN and TfRc contents did not differ from that of IS animals, whereas Tf was significantly reduced (p = 0.048).
Within the fetus, both diet (p = 0.020) and PAE (p = 0.003) increased liver FTN in the IS and IF fetuses (Fig. 3A) , although the additional increase was only a trend for the IF fetuses (p = 0.13). PAE and maternal diet did not affect fetal liver TfRc or Tf (Fig. 3B,C) . In fetal brain, diet did not affect the content of these 3 proteins (Fig. 3E-G) . However, within the developing brain, PAE significantly reduced the content of both FTN (p < 0.001) and Tf (p = 0.007), and iron fortification did not counter these effects of alcohol. IF-PAE fetal brain had significantly lower FTN content when compared to IS-M brain (p = 0.0071). Values are means AE SEM, n = 3 to 4 except liver iron, n = 6. Labeled means within a row without a common letter differ in the post hoc comparison at p < 0.05; means without letters did not significantly differ. IS, iron-sufficient; IF, iron-fortified; M, maltodextrin; MCH, mean cell hemoglobin; MCHC, mean cell hemoglobin concentration; MCV, mean cell volume; PAE, prenatal alcohol exposure; RBC, red blood cell; RDW, RBC distribution width; TIBC, total iron binding capacity; TSAT, transferrin saturation. Values are means AE SEM, n = 3 to 4. Labeled means within a row without a common letter differ in the post hoc comparison at p < 0.05; means without letters did not significantly differ. IF, iron-fortified; IS, iron-sufficient; M, maltodextrin; MCH, mean cell hemoglobin; MCHC, mean cell hemoglobin concentration; MCV, mean cell volume; nRBC, nucleated RBC in peripheral circulation; PAE, prenatal alcohol exposure; RBC, red blood cell; cWBC, white blood cell count corrected for nucleated RBC; Liver nRBC %, % of hepatic surface area containing nucleated RBC. b IS-M and IS-PAE blood hematology (RBC, hemoglobin, hematocrit, MCV, MCH, and MCHC) are reproduced from Huebner and colleagues (2016) and are presented here for comparative purposes against IF values, which have not been previously reported.
Maternal and Fetal Hematologic Parameters
We previously reported that, even though their dams consumed an IS diet, PAE-exposed fetuses exhibited a normocytic anemia that became hypochromic anemia under ID-PAE (Huebner et al., 2016) . The normalized hepcidin and iron regulatory proteins in the IF-PAE fetuses suggested iron fortification may have normalized their iron distribution. To test this, we compared the complete red cell counts in IF-M and IF-PAE dams and fetuses against those from IS-M and IS-PAE. In dams, independent of PAE status, iron fortification elevated RBC (p < 0.001), hemoglobin (p < 0.001), and hematocrit (p = 0.001) values compared to IS (Table 2); panels present overall p-values as determined by 2-factor ANOVA, followed by post hoc analysis in which means without a common letter are significantly different, p < 0.05. IS, iron-sufficient; IF, iron-fortified; M, maltodextrin; PAE, prenatal alcohol exposure; FTN, ferritin; TfRc, transferrin receptor; Tf, transferrin. The IS-M and IS-PAE dams studied here were previously studied in Huebner and colleagues (2016) , but the presented values were generated from a separate aliquot of frozen liver that has not been previously analyzed. The IF values have not been previously reported. however, these elevated values were still within normal ranges for the rat (Quesenberry and Carpenter, 2004) . Iron status and PAE also interacted to affect RBC numbers (p = 0.02) and hematocrit (p = 0.045), and post hoc analysis revealed that IF reversed the reductions in RBC and hematocrit that were observed in the IS-PAE dams (Table 2; Huebner et al., 2016) . Neither maternal diet nor PAE significantly affected maternal erythrocyte indices including MCV, MCH, MCHC, and RBC distribution.
With respect to the fetus, we previously reported that PAE significantly reduced RBC numbers (p = 0.025), hemoglobin (p = 0.034), and hematocrit (p = 0.034), even when their dams consumed an IS diet (Table 3) . Fetuses from iron-supplemented pregnancies had higher RBC (p = 0.0002), hemoglobin (p = 0.001), and hematocrit values (p < 0.001) regardless of their alcohol exposure status, and these values were significantly improved in the IF-PAE fetuses compared with their IS-PAE counterparts. These elevated red cell indices suggested that the extra iron may have stimulated erythropoiesis and, in support of this, the RBCs in the IF fetuses had a larger MCV (p = 0.002) and the appropriate hemoglobin content for their increased cell size as shown by higher MCH (p = 0.012) and normal MCHC, and this appearance was consistent with a normochromic phenotype. Although IF diet increased the nucleated RBC count (p < 0.001), review of Wright-Giemsa blood smears failed to reveal signs of maternal or fetal megaloblastic RBC or hypersegmented neutrophils, as seen with folate or B12 deficiency. Quantitation of RBC pockets along the sinusoids of fetal liver showed that immature RBC numbers were elevated in the IS-PAE liver, and these values were normalized by the IF diet in the presence of PAE. Taken together, these data show that iron fortification reversed the fetal red cell anemia caused by PAE.
Maternal and Fetal Iron Content
We investigated whether iron fortification also normalized fetal iron distribution, as this is significantly disrupted by PAE (Huebner et al., 2016) . Dams consuming the IF diet had significantly increased liver iron content (p < 0.001), independent of their alcohol exposure, and consistent with their increased iron intake (Table 2) ; PAE did not affect hepatic iron content in those dams. In the fetus, PAE significantly increased hepatic iron content (p < 0.001) and this represented both total and nonheme iron (Fig. 4A) . Although hepatic iron was also increased in IF-PAE, this likely represented an effect of dietary iron and not PAE, as liver nonheme iron content did not differ in IF-M and IF-PAE. In fetal brain, alcohol also affected both total (p = 0.015) and nonheme brain iron contents (p < 0.001), as reflected in sharply reduced brain iron content in the IS fetus (Fig. 4B) . Importantly, dietary iron fortification to the mother reversed that decline and total iron and nonheme iron content was normalized in the IF-PAE fetal brain.
To gain insight into the relationship between iron storage and hepcidin under PAE, we compared the distribution of iron between liver stores (nonheme iron) and the erythron (total RBC iron) and brain (nonheme iron) compartments (Fig. 4C,D) . In the nonalcohol-exposed fetuses, iron status significantly affected iron distribution to the erythron (p = 0.0043) and brain (p = 1.53 9 10 À7 ), such that the ratio of liver-to-tissue iron increased commensurate with maternal iron uptake. This is expected and reflects that, under normal conditions, iron is prioritized to the erythron and developing brain; the nonheme liver iron/tissue iron is an order of magnitude lower for the erythron compared with brain under ID, consistent with the higher priority assigned to erythropoiesis. In contrast, PAE significantly skewed the relationship between liver storage iron and erythron iron (p = 0.0017) and brain iron (p = 2.2 9 10 À16 ). In the erythron, iron was disproportionately allocated to liver stores under ID, and the liver stores/RBC iron ratio was independent of iron intake during PAE (Fig. 4C) . In brain, an interaction between iron status and PAE (p = 2.06 9 10
À11
) was associated with significantly elevated liver/brain iron ratios under ID and IS, and this ratio declined as iron intake increased (Fig. 4D) . These data reinforce the hypothesis that, under PAE, iron is directed to liver instead of to the RBCs and brain, even when iron is limiting.
We then compared the relationship between fetal iron distribution and hepcidin. This comparison was made at the treatment level because technical limitations precluded assay of liver iron content and hepcidin expression in the same fetus. We observed a positive relationship between hepcidin and iron storage, such that the hepcidin increases were linearly related to the increased fraction of hepatic iron storage relative to the iron content of the erythron (Fig. 4E ) and brain (Fig. 4F) .
Markers of Iron Overload and Oxidative Stress
Excessive iron intake in pregnancy has been linked to poor perinatal outcomes (Casanueva and Viteri, 2003) . With respect to the dam, PAE did not affect maternal plasma TIBC and TSAT, and the IF diet did not further influence those values (Table 2) . Iron fortification can reduce the bioavailability of other divalent metals due to direct competition for transport and export. The IF diet modestly elevated the zinc content of maternal liver (p = 0.004) and fetal liver (p < 0.001), and tended to increase it in fetal brain (p = 0.07) ( Table S2 ). The IF diet also increased the copper content of maternal liver (p < 0.001), fetal liver (p = 0.051), and fetal brain (p = 0.051). PAE (p = 0.003) increased zinc in fetal liver, and no iron-PAE interaction affecting the mineral content of these tissues was found. Overall, the IF diet did not negatively impact zinc and copper availability for the dam and fetus. Excessive tissue iron also can promote oxidant stress through Fenton chemistry. Thus, we quantified levels of protein carbonylation in maternal liver. We found no Fig. 4 . Iron status and PAE affect total and nonheme iron content in GD20.5 fetal liver and brain. (A) Mean iron content in fetal liver, normalized to liver wet weight. Open bar represents total iron, and shaded bar represents nonheme iron. (B) Mean iron content in fetal brain, normalized to brain wet weight. Open bar represents total iron, and shaded bar represents nonheme iron. (C) Ratio of nonheme liver iron (from A) to total RBC iron, plotted as a function of iron status and alcohol treatment. Total RBC iron is calculated using the formula: mg Fe in circulation = blood volume (90 ml/kg rat weight) 9 hemoglobin (g/ml) 9 3.47 mg Fe/g hemoglobin (Fomon et al., 1988) . differences in protein carbonyl content with respect to alcohol exposure or iron intake (Fig. S1 ).
DISCUSSION
The most important finding from this study is the demonstration that maternal dietary iron fortification significantly improved iron distribution and utilization within the fetus. Infants born to binge-drinking mothers are more likely to have ID anemia, and those infants have greater growth deficits and head circumference reductions than those who were iron-adequate (Carter et al., 2007 (Carter et al., , 2012 . In animal models, ID and PAE interact to worsen growth and behavioral outcomes (Huebner et al., 2015 (Huebner et al., , 2016 Rufer et al., 2012) . The basis for this interaction may be, in part, because PAE alters iron distribution within the fetal compartment and thus hinders the ability of tissues to control their iron status (Huebner et al., 2016; Miller et al., 1995) . Our demonstration here that dietary iron fortification normalizes hepcidin expression, brain iron content, and erythropoiesis within the fetal compartment endorses that dietary approaches including iron fortification should be further explored as potential interventions to improve outcomes in alcohol-exposed human pregnancies. These findings have additional clinical relevance as both human and rat fetuses experience a rapid growth spurt at the end of pregnancy and must accumulate significant iron stores prenatally, because their postnatal growth outstrips the iron quantity delivered by milk. Thus, prenatal iron deposition is necessary in both rat and human to offset the risk of postnatal ID during lactation.
The dietary iron fortification improved maternal and fetal hematologic parameters, which impose a substantial burden on iron stores due to the rapid expansion of maternal and fetal circulation during pregnancy. Although the IS dams were not anemic, they had lower RBC numbers and the ironfortified diet increased the hematologic values of IF-PAE dams such that these were now indistinguishable from those of IF-M dams. This suggested that iron stores were limiting for erythropoiesis in the IS-PAE dams and, potentially, that the IF dams achieved a more effective delivery of oxygen to the placenta. This hematologic improvement was even more dramatic in the PAE fetus. Whereas IS-PAE fetuses were overtly anemic, the dietary intervention reversed this anemia, and the IF-PAE fetuses exhibited hematologic indices that were indistinguishable from those of IF-M fetuses. This indicated that the IF diet improved iron delivery and/or utilization by the fetal erythron, needs that were unmet under conditions of IS-PAE. Under most physiological circumstances, including anemia, iron delivery to the fetal erythrocytes is prioritized over other iron-dependent tissues such as brain (Zamore et al., 2016) . However, under limited conditions including inflammation (Fisher and Nemeth, 2017) and (now) PAE (Huebner et al., 2016) , iron delivery is not prioritized to fetal erythrocytes and is instead routed to storage. The inability of IS-PAE, but not IF-PAE, fetuses to maintain RBC production suggests that PAE disturbed the ability to fulfill that priority, and our calculations of tissue iron partitioning support this interpretation. Although iron fortification was associated with larger MCVs, further investigation revealed this did not represent megaloblastic anemia, but rather the increased presence of nucleated RBCs, suggesting IF promoted erythropoiesis in the PAE fetus. Iron supplementation is known to stimulate erythropoiesis and nucleated RBC release (Kling et al., 2008) . The vulnerability of PAE fetuses to anemia gains significance because maternal iron inadequacy is present in populations at high risk for FASD (May et al., 2014 (May et al., , 2016 Streissguth et al., 1983 ). An improved fetal erythron would benefit fetal development particularly with respect to brain and in other organ systems as well.
Improvement of the erythron in IF-PAE fetuses was accompanied by improved iron status in IF-PAE brain. The developing brain is a major target of iron-PAE interactions, and ID synergizes with alcohol to reduce associative learning, myelination, and head circumference in the offspring (Carter et al., 2007 (Carter et al., , 2013 Rufer et al., 2012) . Even when the mother is iron-adequate, PAE causes lasting reductions in brain iron content (Miller et al., 1995) . Iron is essential for healthy brain development, and thus, it is noteworthy that dietary iron fortification normalized fetal brain iron status such that total brain iron was equivalent between IF-PAE and IS-M and IF-M controls. Nonheme iron, which better reflects the nonvascular iron content in these unperfused brains, had a greater content in the IF brains regardless of alcohol exposure, indicating an improved iron status. A greater proportion of this nonheme iron likely represents nonstorage forms because the PAE brains also had reduced ferritin content. The iron adequacy of the IF-PAE brain is further supported by its normal Tf and TfRc contents, which otherwise increases in response to iron insufficiency. Although iron still accumulated in the liver of PAE fetuses, the accrual of nonheme iron in IF-PAE brain combined with normal Tf and TfRc suggests the IF diet potentially promoted the more effective use of iron within the fetus.
Although this study was not designed to identify the mechanism by which iron fortification normalized iron distribution and iron status, an important clue emerged from the demonstration that the IF diet normalized fetal and maternal hepcidin expression in alcohol's presence, such that hepcidin levels in IF-PAE were indistinguishable from those in IS-M and IF-M. Hepcidin is a peptide hormone synthesized by liver and a "master regulator" of iron homeostasis. Under iron sufficiency or iron excess, hepatic hepcidin output increases to reduce intestinal iron absorption and direct iron into storage, thereby limiting iron circulation. Conversely, under times of ID, hepcidin production decreases, signaling the liver to release iron from storage and into the bloodstream (Pantopoulos et al., 2012) . Within the fetal compartment, hepcidin similarly acts to regulate placental transfer of maternal iron and its distribution into storage or target tissues. Our studies (Huebner et al., 2016 and herein) reveal that alcohol disrupts this relationship between iron status and hepcidin, such that alcohol increased the fractional storage of iron relative to that in erythron and brain under conditions when iron was limiting. This shift was linearly related to the increased hepcidin production and suggests that the attenuated hepcidin in IF-PAE favored the redirection of fetal iron toward brain and erythron. Previous studies have shown that alcohol decreases hepcidin in adult humans with alcoholic liver disease, and in animal models of both acute exposure and chronic exposure (Harrison-Findik, 2009; Ohtake et al., 2007; Varghese et al., 2016) . In contrast, gestational alcohol exposure increases hepcidin mRNA in both dam and fetus (Huebner et al., 2016) . Although these latter results are seemingly incongruous with prior work, one contribution to this elevated hepcidin may be alcohol's proinflammatory properties. Cytokines including IL-6 and IL-1b stimulate hepcidin transcription (Lee et al., 2005) , and our preliminary findings observe dysregulated cytokine production in response to alcohol and iron status in dams and fetuses (Saini N, Helfrich KK, Huebner SM, Abazi J, Kling PJ, Smith SM preparation). An additional contribution to the elevated hepcidin levels in PAE may be the incomplete erythropoiesis observed in the IS-PAE and ID-PAE fetuses (Huebner et al., 2016) . Although we did not measure erythropoiesis directly, the reduced hematocrits in the IS and ID fetuses are consistent with such a mechanism, and the IF diet may have ameliorated this by enhancing the pool of available (nonstorage) iron.
PAE has complex effects upon growth and can result in delayed prenatal and/or postnatal growth, catch-up growth, or no growth delays at all (Carter et al., 2016) . ID at infancy worsens these postnatal growth delays at 6 months (trend) and 12 months of age, but not in childhood (Carter et al., 2007 (Carter et al., , 2012 . Rat models of PAE support those clinical findings and show that ID interacts with alcohol to worsen fetal and postnatal growth, compared with IS-PAE controls (Huebner et al., 2016; Rufer et al., 2012) . PAE exerts multiple influences upon offspring growth by affecting nutrient availability (Sawant et al., 2015) , placental function (Lo et al., 2017) , and perhaps metabolic programming (Lunde et al., 2016) , among others. Collectively, these clinical and rodent model findings affirm that iron status is an important modulator of growth in FASD, and worsened growth outcomes occur, in part, in those pregnancies in which iron was limiting.
In summary, this study shows that maximizing maternal iron stores prior to and during pregnancy can mitigate the deleterious effects of high-dose alcohol exposure on fetal erythrocyte-iron delivery. A limitation is that we do not know if the benefit was derived from the iron preload prior to pregnancy, from the gestational supplementation, or both, and this must be ascertained because elevated hepcidin in heavydrinking pregnancies would reduce dietary iron absorption. The increased nonstorage iron content in IF-PAE brain suggests greater iron availability for neurodevelopmental processes such as monoamine neurotransmitter synthesis and myelination (Georgieff, 2007) , and studies to test the impact of iron fortification on neurobehavioral outcomes in PAE are underway. However, the decision to fortify with iron during pregnancy is complex. Diagnosing ID is not always straightforward, as maternal anemia during the third trimester can be attributed to normal physiology during pregnancy (Scholl, 2005) . Supplementation during this period can be detrimental, because high doses promote Fenton peroxidation and may increase susceptibility to developing gestational diabetes (Chen et al., 2006; Lachili et al., 2001) . Promotion of iron supplements during pregnancy is consistent with public health policy, and results here show that oral iron delivery can improve maternofetal iron status under conditions of PAE. However, we used an IF diet rather than a concentrated oral iron supplement, and we note the latter can be associated with symptoms such as gastrointestinal stress, abdominal cramping, nausea, and constipation, which may deter many pregnant women (Pereira et al., 2014; Smith et al., 2014) . ID is common in both developed and developing countries (Scholl, 2005) , including areas where alcohol abuse is high in pregnant women (May et al., 2014 (May et al., , 2016 . Although fetal outcomes would be most improved by limiting maternal alcohol use, this is difficult in practice, and alcohol abuse remains a leading public health problem including for pregnant women (CDC, 2015) . Recently, micronutrient supplementation concurrent with PAE has been shown to improve neurodevelopmental outcomes in the offspring (Coles et al., 2015; Kable et al., 2015) , and our rat model supports this approach to help reduce the infant's vulnerability to PAE.
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